Most Popular
Advertising
Videos & Images
Fun Stuff
Content Section
Booking Portal
News Headlines
3 times read : Adjust font size: 
 |
TOKYO (Reuters) - Astellas Pharma (Tokyo:4503.T - News ), Japan's No.2 drugmaker, agreed to buy U.S. biotech OSI Pharmaceuticals ( OSIP - News ) for billion in cash in a sweetened bid that will add OSI's blockbuster cancer drug Tarceva to its line ...
Read this article...
Comments (0 posted)
